Farms.com Home   News

NAWG Responds to SCOTUS Ruling in Sackett V. EPA Case

By Mariah Wollweber 

Today, the Supreme Court issued a decision in Sackett v. EPA that narrows the extent of federal jurisdiction over bodies of water under the Clean Water Act.

“NAWG is pleased with the rule the Supreme Court issued today that rejected the confusing and expansive “significant nexus” test that broadened the jurisdiction of the Clean Water Act,” said NAWG CEO Chandler Goule. “The Supreme Court ruling sided with a narrower definition of the Clean Water Act jurisdiction and limited the number of wetlands that would come under the regulation of the Clean Water Act.”

Last year, NAWG joined several other agriculture groups in filing a brief with the Supreme Court stating the complexity of the definitions and impact on agriculture. NAWG will continue to advocate that any regulation is limited in scope to navigable waters and provides farmers clarity on which waters are jurisdictional.

About NAWG

NAWG is the primary policy representative in Washington D.C. for wheat growers, working to ensure a better future for America’s growers, the industry and the general public.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.